Article and Video CATEGORIES
Drs. Nate Pennell from Cleveland Clinic and Mary Pinder from Moffitt Cancer Center in Tampa, FL sat down with our own Dr. Jack West to discuss early impressions of some of the most provocative research presented at the American Society for Clinical Oncology (ASCO) Annual Meeting in Chicago in early June.
Here's a growing list of podcasts covering the topics they discussed:
Is it possible to test for biomarkers in lung cancer on a national scale?
Is there a role for molecular markers predicting the best chemotherapy to use in lung cancer?
Can we predict which patients will benefit from Tarceva based on a blood test?
Do you need Avastin in first line and maintenance therapy in advanced NSCLC?
Is there a best Avastin-containing regimen for first line and maintenance therapy in advanced NSCLC?
Can we harness our immune system to fight NSCLC?
Can we improve on XALKORI? New agents for patients with an ALK-1 rearrangement
Is Nintedanib a new agent worthy of becoming a new treatment for advanced NSCLC?
Are molecular markers just for NSCLC?
Could BRAF be a new target in NSCLC?
Can we target KRAS effectively in advanced NSCLC?
What have we learned from the START trial of immunotherapy in locally advanced NSCLC?
How do we approach acquired resistance to targeted therapies in lung cancer?
How should we integrate new immunotherapies into treatment strategies for lung cancer?
Is there a place for maintenance therapy in extensive stage SCLC?
This completes the series. We hope you found this content useful.
We thank Drs. Nate Pennell and Mary Pinder for their generosity with their time and expertise in providing this information to the lung cancer community.
We also thank LUNGevity for sponsoring this video series.
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi Revtoby, Welcome to Grace. I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...
Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...
Hello and welcome to Grace. I'm sorry you're going through this worry. It is normal to watch a small very slow-growing solid nodule with once-a-year CT scans. Anything less than a...
Thanks you very much. So in summary the course of action taken suggested by lung specalist (re scan in 12 months) seems appropriate? And a PET at this stage is probably...
I can't say what is appropriate for you that's only something your professionals with all your information can do. However, when someone has a solid nodule less than a cm that...